Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
11.33
-0.10 (-0.87%)
At close: Aug 15, 2025, 3:59 PM
11.80
4.15%
After-hours: Aug 15, 2025, 06:53 PM EDT
Cartesian Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 298K | 1.1M | -759K | 387K | 33.45M | 5.84M | 8.27M | 6.55M | 5.25M | 5.94M | 16.8M | 20.71M | 39.27M | 34M | 29.94M | 24.43M | 19.66M | 11.05M |
Cost of Revenue | n/a | n/a | n/a | n/a | 196K | 183K | 272K | 189K | 626K | 616K | 607K | 539K | 498K | 644K | n/a | n/a | n/a | n/a |
Gross Profit | n/a | 1.1M | -759K | 387K | 33.25M | 5.66M | 7.99M | 6.36M | 4.62M | 5.32M | 16.19M | 20.17M | 38.77M | 33.35M | 29.94M | 24.43M | 19.66M | 11.05M |
Operating Income | -21.81M | -21.89M | -26.73M | -17.57M | 13.76M | -13.35M | -36.33M | -13.06M | -18.64M | -18.38M | -8.5M | -1.6M | 13.86M | 10.77M | 4.08M | -1.97M | 452K | -7.16M |
Interest Income | 1.75M | n/a | 7.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.14M | 710K | 207K | 15K | 9K | 11K | 12K | 12K |
Pretax Income | 15.89M | -17.71M | -9.97M | -24.18M | 13.84M | -56.82M | -196.66M | -9M | -11.39M | -21.66M | 5.61M | -8.21M | 8.6M | 28.78M | 12.38M | -2.07M | 4.57M | -24.6M |
Net Income | 15.89M | -17.71M | -10.25M | -24.18M | 13.84M | -56.82M | -177.66M | -9M | -11.39M | -21.66M | 5.89M | -7.89M | 8.6M | 28.78M | 12.24M | -17.89M | 4.57M | -24.6M |
Selling & General & Admin | 7.24M | 8.31M | 7.09M | 6.56M | 7.03M | 9.45M | 22.17M | 6.61M | 6.11M | 5.7M | 5.72M | 5.23M | 5.73M | 4.89M | 5.22M | 4.82M | 4.17M | 4.72M |
Research & Development | 14.87M | 14.67M | 11.31M | 11.4M | 12.66M | 9.74M | 22.43M | 13M | 17.78M | 18.62M | 18.97M | 16.54M | 19.18M | 17.69M | 20.32M | 20.95M | 14.46M | 13M |
Other Expenses | n/a | n/a | 7.58M | n/a | n/a | n/a | -62K | n/a | 245K | 255K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 22.11M | 22.99M | 25.97M | 17.96M | 19.69M | 19.19M | 44.6M | 19.62M | 23.89M | 24.32M | 24.68M | 21.77M | 24.91M | 22.58M | 25.54M | 25.77M | 18.63M | 17.73M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.27M | 752K | 808K | 807K | 802K | 715K | 707K | 711K | 711K | 711K | 711K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 22.99M | 25.97M | 17.96M | 19.69M | 19.19M | 44.6M | 19.62M | 23.89M | 24.32M | 25.29M | 22.31M | 25.41M | 23.23M | 25.86M | 26.4M | 19.21M | 18.21M |
Income Tax Expense | n/a | n/a | 287K | n/a | n/a | n/a | -19M | n/a | n/a | n/a | -288K | -321K | n/a | n/a | 138K | 15.83M | n/a | n/a |
Shares Outstanding (Basic) | 25.98M | 25.9M | 25.91M | 21.47M | 16.72M | 5.41M | 5.17M | 5.16M | 5.11M | 5.11M | 4.83M | 5.09M | 4.95M | 4.14M | 3.84M | 3.84M | 3.15M | 3.08M |
Shares Outstanding (Diluted) | 26.45M | 25.9M | 25.91M | 21.47M | 17.79M | 5.41M | 5.17M | 5.16M | 5.11M | 5.11M | 4.83M | 5.09M | 4.95M | 4.14M | 3.84M | 3.84M | 3.37M | 3.08M |
EPS (Basic) | 0.51 | -0.68 | -0.07 | -3.39 | 0.58 | -10.5 | -34.43 | -1.74 | -2.23 | -4.24 | 1.16 | -1.5 | 1.74 | 6.95 | 3.12 | -4.66 | 1.21 | -6.66 |
EPS (Diluted) | 0.50 | -0.68 | -0.07 | -3.39 | 0.54 | -10.5 | -34.43 | -1.74 | -2.23 | -4.24 | 1.16 | -1.55 | 1.74 | 6.77 | 2.96 | -4.66 | 1.13 | -6.66 |
EBITDA | -21.81M | -20.73M | -9.48M | -23.9M | 14.03M | -56.64M | -196.39M | -7.54M | -10.01M | -20.24M | 7.02M | -6.87M | 9.81M | 30.13M | 13.41M | -733K | 5.86M | -23.41M |
EBIT | n/a | -21.89M | -9.97M | -24.18M | 13.84M | -56.82M | -196.66M | -7.73M | -10.63M | -20.86M | 6.41M | -7.41M | 9.32M | 29.48M | 13.09M | -1.35M | 5.28M | -23.89M |
Depreciation & Amortization | n/a | 1.16M | 486K | 286K | 196K | 183K | 272K | 189K | 626K | 616K | 607K | 539K | 498K | 644K | 323K | 622K | 582K | 479K |